# Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo

> **NCT06394349** · NA · UNKNOWN · sponsor: **Yijian Zhu** · enrollment: 20 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **COMBINATION_PRODUCT:** PRP+308nm
- **COMBINATION_PRODUCT:** NS+308nm

## Key facts

- **NCT ID:** NCT06394349
- **Lead sponsor:** Yijian Zhu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-22
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-10-14
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06394349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06394349, "Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06394349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*